Acadian Asset Management »

Immunovant shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $96k 3.4k 28.26

More positions owned by Acadian Asset Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Check Point Software Tech Ord (CHKP)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Logitech Intl S A SHS (LOGI)
Colgate-Palmolive Company (CL)
Spotify Technology S A SHS (SPOT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Booking Holdings (BKNG)
Cintas Corporation (CTAS)
Marsh & McLennan Companies (MMC)
Wix SHS (WIX)
NetApp (NTAP)

View all positions for Acadian Asset Management

Top funds holding Immunovant

Vanguard Group
BlackRock
BlackRock
Armistice Capital
T. Rowe Price Investment Management
Deep Track Capital
State Street Corporation
Perceptive Advisors
Viking Global Investors
Alpine Partners VI
Geode Capital Management
Woodline Partners
Paradigm Biocapital Advisors
Pictet Asset Management Holding SA
Baker Bros. Advisors

View all funds holding Immunovant